Micron Biomedical, Inc.

Atlanta, Georgia, United States


Purpose

to develop a measles and rubella vaccine microarray patch that meets the preferred product characteristics and contributes to global measles and rubella elimination

Division

Global Development, Global Health

Date

June 2017

Region Served

GLOBAL

Committed amount

$2,313,835

Grant topic

Pneumonia & Pandemic Preparedness, Vaccine Delivery

Duration (months)

30

Grantee location

Atlanta, Georgia, United States

Related work

Immunization

Pneumonia

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.